https://www.selleckchem.com/pr....oducts/PD-0332991.ht
cells following cisplatin. Patients with Xeroderma pigmentosum can be carriers of defective Xeroderma pigmentosum complementation group C and if the degree of Xeroderma pigmentosum complementation group C inactivity is significant, fatalities could occur. Physicians should be aware of this rare but potentially lethal toxicity when considering systemic therapy for squamous cell carcinoma in patients diagnosed with Xeroderma pigmentosum.Importance Septorhinoplasties are performed for functional, aesthetic, or a combination of these ind
Like
Comment
Share
